Kfar Saba, Israel

Zvi Harel

This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Teva Pharmaceutical Industries Limited, Sicor Inc.. Active years: 2006-2014.


% Patents Active = 40.0

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Zvi Harel: Innovator in Pharmaceutical Processes

Introduction

Zvi Harel is a notable inventor based in Kfar Saba, Israel, recognized for his contributions to pharmaceutical innovations. With a total of five patents to his name, he has made significant strides in the field of drug formulation and preparation.

Latest Patents

Harel's latest patents include processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid. These processes allow for the direct preparation of pemetrexed disodium salt from pemetrexed diacid or its salts, eliminating the need for prior isolation of the obtained pemetrexed salt before lyophilization. Another significant patent involves Varenicline tosylate, which serves as an intermediate in the preparation of varenicline L-tartrate. This patent provides crystalline forms of Varenicline Tosylate and outlines processes for obtaining high purity Varenicline base using Varenicline Tosylate.

Career Highlights

Throughout his career, Zvi Harel has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceutical Industries Limited and Sicor Inc. His work has contributed to advancements in drug formulation and delivery systems.

Collaborations

Harel has collaborated with several professionals in the field, including Rami Lidor-Hadas and Revital Lifshitz-Liron. These collaborations have further enhanced his innovative contributions to pharmaceutical processes.

Conclusion

Zvi Harel's work in the pharmaceutical industry exemplifies the impact of innovation on drug development. His patents and collaborations reflect a commitment to advancing healthcare through effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…